Financial Institutions, Inc. Announces Retirement of CFO Kevin B. Klotzbach
Apr 30, 2018 20:05 pm UTC| Business
WARSAW, N.Y., April 30, 2018 -- Financial Institutions, Inc. (NASDAQ:FISI) (the “Company”), parent company of Five Star Bank (the “Bank”), Scott Danahy Naylon, LLC and Courier Capital, LLC, announced today that Kevin B....
Apr 30, 2018 20:05 pm UTC| Business
- Oral Selinexor Achieves 25.4% Overall Response Rate and Median Duration of Response of 4.4 Months in Patients with Penta-Refractory Myeloma - - Company Plans to Submit a New Drug Application to the FDA in the Second...
OurPet’s Company Reports First Quarter 2018 Results
Apr 30, 2018 20:05 pm UTC| Business
FAIRPORT HARBOR, Ohio, April 30, 2018 -- OurPet’s Company (OTCQX:OPCO) (www.ourpets.com), a leading proprietary pet supply company, today reported operating results for the three months ended March 31, 2018. ...
Varonis Announces First Quarter 2018 Financial Results
Apr 30, 2018 20:05 pm UTC| Business
Total revenues of $53.5 million, up 35% year-over-year License revenues of $25.1 million, up 39% year-over-year NEW YORK, April 30, 2018 -- Varonis Systems, Inc. (Nasdaq:VRNS), a pioneer in data security and...
EFI Reports Record First Quarter Revenue For Q1 2018
Apr 30, 2018 20:05 pm UTC| Business
FREMONT, Calif., April 30, 2018 -- Electronics For Imaging, Inc. (Nasdaq:EFII), a world leader in customer-focused digital printing innovation, today announced its results for the first quarter of 2018. For the...
Black Knight Announces Amended and Restated Credit Facilities
Apr 30, 2018 20:05 pm UTC| Business
JACKSONVILLE, Fla., April 30, 2018 -- Black Knight, Inc., a Delaware corporation (NYSE:BKI) (“Black Knight” or “BKI”), a leading provider of software, data and analytics solutions to the mortgage and consumer loan, real...
miRagen Therapeutics to Participate in Upcoming Investor Conferences
Apr 30, 2018 20:05 pm UTC| Business
BOULDER, Colo., April 30, 2018 -- miRagen Therapeutics, Inc. (NASDAQ:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that William S....